Autobio Diagnostics Co., Ltd.

XSSC:603658 Stock Report

Market Cap: CN¥33.4b

Autobio Diagnostics Past Earnings Performance

Past criteria checks 4/6

Autobio Diagnostics has been growing earnings at an average annual rate of 14.9%, while the Medical Equipment industry saw earnings growing at 8.9% annually. Revenues have been growing at an average rate of 15.2% per year. Autobio Diagnostics's return on equity is 14.7%, and it has net margins of 28.9%.

Key information

14.9%

Earnings growth rate

13.4%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate15.2%
Return on equity14.7%
Net Margin28.9%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Autobio Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSSC:603658 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 244,4961,300949655
31 Dec 234,4441,217941656
30 Sep 234,4031,169925633
30 Jun 234,4791,180915627
31 Mar 234,4471,169864600
31 Dec 224,4421,167874568
30 Sep 224,3521,156879540
30 Jun 224,1591,095827508
31 Mar 223,9801,042810498
31 Dec 213,766974772481
30 Sep 213,626950733445
30 Jun 213,450887713420
31 Mar 213,245826665376
31 Dec 202,978748616343
30 Sep 202,833751587322
30 Jun 202,706728574321
31 Mar 202,682746560318
31 Dec 192,679774564312
30 Sep 192,463689524294
30 Jun 192,261636467261
31 Mar 192,062588445229
31 Dec 181,930563404213
30 Sep 181,777534383188
30 Jun 181,666502292234
31 Mar 181,574475307191
31 Dec 171,400447301143
30 Sep 171,27141929399
30 Jun 171,1293933550
31 Mar 171,0303633240
31 Dec 169803503010
30 Sep 168983352600
30 Jun 168373172250
31 Mar 167522782200
31 Dec 157162782030
31 Dec 145632081730
31 Dec 134091241500

Quality Earnings: 603658 has high quality earnings.

Growing Profit Margin: 603658's current net profit margins (28.9%) are higher than last year (26.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 603658's earnings have grown by 14.9% per year over the past 5 years.

Accelerating Growth: 603658's earnings growth over the past year (11.1%) is below its 5-year average (14.9% per year).

Earnings vs Industry: 603658 earnings growth over the past year (11.1%) exceeded the Medical Equipment industry -1.4%.


Return on Equity

High ROE: 603658's Return on Equity (14.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.